Michael Patterson, CEO at US Cannabis Pharmaceutical Research and Development

Michael Patterson is the CEO of US Cannabis Pharmaceutical Research and Development LLC (US Cannabis), a privately-held developmental consulting firm that was established in 2014 with the mission of moving society forward through legalized cannabis.  US Cannabis develops the legal cannabis/hemp/CBD markets globally across all platforms (education, cultivation, production, dispensing, research and development, management operations and compliance, and physician services).  US Cannabis currently works with national, state, and local governments, sovereign nations, and public/private companies in all aspects of the cannabis/hemp/CBD industry throughout the United States and Internationally.  Mr. Patterson is a board member of MGMC-Pharma, an international medical cannabis pharmaceutical corporation with cannabis cultivation, production, and export/distribution licenses in 5 East African Countries (Lesotho, Tanzania, Malawi, Democratic Republic of Congo, Uganda).Mr. Patterson is also a board member for the Medical Cannabis Society, Tourette’s Syndrome Awareness Foundation, Cannabis/Hemp/CBD industry writer for Florida MD Magazine, Orlando Medical News, and licensed Occupational Therapist and Nursing Home Administrator in 4 states: NJ, NC, VA, FL).